Patient on Prednisone? Don’t Miss These Baseline Labs

Glucocorticoids like prednisone are a cornerstone in the treatment of inflammatory and autoimmune conditions. They offer fast, reliable symptom relief and are life-saving in the management of adrenal insufficiency. However, these benefits come with well-documented risks — many of which can emerge within weeks of therapy initiation.

Despite this, most patients begin corticosteroid therapy without appropriate baseline testing or monitoring strategies in place. This gap in care represents an opportunity for Naturopathic and Integrative clinicians to intervene early, reduce iatrogenic complications, and position themselves as long-term partners in chronic disease management.

The Physiological Impact of Prednisone

Prednisone doesn’t just suppress inflammation — it affects multiple systems, often within days of the first dose. Many of these changes go unrecognized unless we are proactively screening for them.

Key physiological changes include:

• Glycemic dysregulation: Corticosteroids reduce insulin sensitivity and increase hepatic gluconeogenesis, leading to hyperglycemia.

   

• Lipid changes: Triglycerides and LDL cholesterol can rise with continued therapy.

   

• Hypertension: Sodium and fluid retention, along with increased vascular tone, can elevate blood pressure even with moderate doses.

   

• Body composition: Fat redistribution (especially central adiposity) and muscle catabolism are commonly reported, particularly with prolonged or high-dose use.

• Bone metabolism: Glucocorticoids reduce osteoblast activity and increase bone resorption. Bone loss begins rapidly — often within 3 to 6 months of treatment — and contributes to glucocorticoid-induced osteoporosis, a leading cause of secondary osteoporosis. 

These are not hypothetical risks. One Canadian study found that fewer than 15% of patients prescribed glucocorticoids for longer than 6 months received a bone density scan — highlighting how often this risk is overlooked.

Recommended Baseline Testing

If the patient has not yet had baseline investigations completed, the best time to run these tests is now — regardless of where they are in their treatment timeline.

Suggested baseline labs and assessments:

• HbA1c and fasting glucose: Early identification of impaired glycemic control is essential.

   

• Lipid panel: Total cholesterol, LDL, HDL, and triglycerides.

   

• Blood pressure: At least two readings, if possible.

   

• Waist circumference: A cost-effective and predictive anthropometric marker for cardiometabolic risk.

   

• 25-hydroxyvitamin D and serum calcium: To assess for underlying insufficiency and monitor bone health.

• Bone Mineral Density (BMD): Consider especially in patients expected to take prednisone >3 months, those with additional risk factors, or a history of fragility fractures.

These tests are accessible and relatively inexpensive. More importantly, they allow for early intervention and risk stratification — a hallmark of preventative care in integrative practice.

How to Communicate Risk Without Creating Alarm

Patients may express hesitancy or concern when prescribed prednisone, particularly when they’re aware of its potential side effects. While their fears may be valid, they often lack context. Your role as a clinician is to normalize monitoring as part of best practice — not just damage control.

Consider the following patient-centered messaging:

• “This is a powerful and necessary medication. Our job is to make sure we’re supporting your body as it adjusts.”

• “Even if we can’t avoid the medication, we can absolutely reduce the risk of complications — but only if we monitor closely.”

• “We’re not just treating today’s problem — we’re protecting your long-term health.”

Reframing monitoring as proactive, personalized care reinforces trust and encourages adherence

Why This Matters

Integrative clinicians are well-positioned to bridge the gap between acute symptom management and long-term wellness — particularly when conventional care fails to address prevention. Baseline assessment before (or during) corticosteroid therapy is a simple intervention that:

• Reduces the risk of metabolic and bone-related complications,

   

• Provides a roadmap for ongoing monitoring, and

   

Signals to both the patient and the care team that you are thinking long-term.

Clinical Takeaway

Glucocorticoid therapy, while effective, carries significant risks — many of which are predictable and preventable with early assessment. Incorporating routine baseline labs into your workflow for patients on prednisone is a small clinical step with a high return on investment.

For every patient currently on systemic glucocorticoids — whether prescribed last week or last year — ensure these baseline labs are part of your care plan. If they weren’t done at the start, the next best time is now.